Alzheimer’s Disease: Taking Contro (NAPSA)—Today in the U.S., approximately 4.5 million people are living with Alzheimer’s—a debilitating disease that robs people of their memory—and 70 percent of these people live with their caregiver. After 65 yearsold, it is estimated that one in 10 Americans are afflicted with Alzheimer’s, but after the age of 85, the incidence rate jumps dramatically to 50 percent. “First I cried and then I took control,” said Mary P., who has been caring for her mother with Alzheimer’s for the last five years. Her sentiment is shared by thousandsof caregivers across the country. Aspart of taking control, Mary P. sought out information about a clinical research study. A nationwide clinical research trial seeks Alzheimer’s patients andtheir caregivers. sible treatment and I wanted information and support for or in an assisted-living facility. They must be 50 yearsor older and have a diagnosis of Alzheimer’s and have not taken medications for Alzheimer’s in the past three months. The study also requires the support of a caregiver who is willing to accompany the Alzheimer’s patient to eachvisit. Clinical studies offer some benefits, such as study-related medical tests, medical care, lab work and close monitoring at no cost. If you or someone you know is caring for a person with advanced Alzheimer’s, consider calling for “T wanted to get Mom into pos- myself,” said Mary P., who enrolled her mother in a clinical research study. “It’s an added benefit to know that you are helping others, too.” Physicians across the U.S. are involved in a clinical research study designed to determine the effectiveness of an investigational medication for the treatment of the more advanced stages of Alzheimer’s disease. To move this research forward, many Alzheimer’s patients and their caregivers are needed to volunteerfor this clinical study. To qualify, the person must be in the more advanced stages of Alzheimer’s disease, living at home more information. The need for patients is great and patients can makea difference. Call toll free 1-877-336-8167 or visit MemoryLossStudies.com. Editor's Note: Theclinical study is available to people in the following states: Alabama;Arizona; California; Colorado; Connecticut; Florida; Georgia;Illinois, Indiana, Kentucky; Louisiana; Maryland; Nevada; New Jersey, New York; North Carolina; Ohio; Oklahoma, Oregon; Pennsylvania; Tennessee; Texas; Virginia; Washington; and Wisconsin.
